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Abstract Nontypeable Haemophilus inﬂuenzae (NTHi)
commonly colonizes the upper respiratory tract of children
and causes otitis media, sinusitis, and bronchitis. Invasive
NTHi diseases such as meningitis and septicemia have
rarely been reported, especially in children with underlying
predisposing conditions such as head trauma and immune
compromise. However, we report a previously healthy
2-year-old girl who developed meningitis and septicemia
caused by NTHi biotype III. She was treated with dexa-
methasone, meropenem, and ceftriaxone, and recovered
uneventfully. We wish to emphasize that NTHi should be
borne in mind as a potential pathogen that can cause
meningitis and septicemia, even in previously healthy
children.
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Introduction
Haemophilus inﬂuenzae type b (Hib) is responsible for
most cases of invasive H. inﬂuenzae disease, including
meningitis and septicemia, in unvaccinated children. With
the decline in the incidence of invasive Hib disease as a
result of the Hib vaccine program, nontypeable H. inﬂu-
enzae (NTHi) has become an important cause of invasive
H. inﬂuenzae disease in vaccinated children [1].
NTHi is part of the normal ﬂora in the upper respiratory
tract of children and commonly causes local respiratory
tract diseases, including otitis media, sinusitis, conjuncti-
vitis, and bronchitis [2, 3]. Meningitis and septicemia have
been reported rarely in children with underlying predis-
posing conditions, including head trauma [4], cerebrospinal
ﬂuid (CSF) leakage [5], and immune compromise [6], in
neonates associated with colonization of the maternal
genital tract [7, 8], and more rarely in previously healthy
children [9–11].
According to a Japanese nationwide surveillance sys-
tem, the incidence of H. inﬂuenzae meningitis was 4.7
cases/100.000/year in 1994 [12]. The frequency with which
NTHi meningitis in children occurs seems to vary,
depending on the populations surveyed: 4 (0.7%) of the
535 patients with H. inﬂuenzae meningitis were NTHi
strains [13]; 2 (4.9%) of the 41 pediatric patients with
H. inﬂuenzae meningitis were NTHi strains [14].
We report a case of a previously healthy 2-year-old girl
who developed meningitis and septicemia caused by NTHi
biotype III, and wish to emphasize that NTHi must be
borne in mind as a potential pathogen that can cause
invasive disease, even in previously healthy children.
Case report
On 7 September 2008 a previously healthy 2-year-old girl
was admitted to the hospital with a 12-h history of fever
and vomiting. She had no rhinorrhea or cough before her
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and her birth weight was 3062 g. Subsequent mental and
physical development had been normal. She had no history
of head trauma, CSF leakage, or immune compromise. She
had been immunized with various vaccines as appropriate
according to the immunization schedule for children
(BCG, diphtheria, tetanus, pertussis, poliomyelitis, mea-
sles, rubella, and varicella). She lived with her parents and
3-year-old brother, and attended a nursery school.
On admission, she had a body temperature of 39.2C,
heart rate of 122 beats/min, respiratory rate of 40/min, and
an instant capillary reﬁll time without cold peripheries.
Consciousness was clear. Ear–nose–throat examination
showed a red and swollen pharynx. No clinical ﬁndings of
otitis media were observed. Examination of her chest and
abdomen was unremarkable. No rashes, anterior fontanelle
bulging or nuchal rigidity was observed. Laboratory data
on admission were: white blood cell (WBC) count, 13400/
ll (neutrophils 91%, monocytes 2%, lymphocytes 7%);
serum aspartate aminotransferase (ALT), 29 IU/l; serum
alanine aminotransferase (AST), 17 IU/l; serum lactate
dehydrogenase (LDH), 252 IU/l; serum C-reactive protein
(CRP), 1.5 mg/dl. An abdominal X-ray showed no abnor-
malities. She was initially treated with intravenous ﬂuid
and antipyretics, with her condition monitored closely.
On the second day of admission, the vomiting persisted,
and the patient complained of headache. She had a body
temperature of 39.3C, heart rate of 145 beats/min, and
respiratory rate of 45/min. She became disoriented and the
Glasgow coma scale showed an eye opening (E) score of 4,
verbal response (V) score of 2, and best motor response
(M) score of 5. Nuchal rigidity and Brudzinski’s sign were
positive. No anterior fontanelle bulging or hemiparesis
were observed, and Kernig’s sign and Babinski’s sign were
negative. The laboratory data on September 8 were: WBC
count, 15300/ll (neutrophils 82%, monocytes 9%, lym-
phocytes 8%); ALT, 30 IU/l; AST, 16 IU/l; LDH, 307
IU/l; fasting blood glucose, 144 mg/dl; CRP, 15.0 mg/dl;
CSF cell count, 3146 cells/ll (polymorphonuclear leuco-
cytes, 78%); CSF protein, 51 mg/dl; CSF glucose,
35 mg/dl. Gram staining of the CSF revealed the presence
of small, Gram-negative, pleomorphic rods resembling
H. inﬂuenzae. However, a CSF test kit designed to detect
the capsular antigens of bacteria causing meningitis
(Pastrorex Meningitis; Bio-Rad Laboratories, Tokyo,
Japan) gave a negative result for Hib antigen. On the basis
of the clinical and laboratory ﬁndings, diagnosis of bacte-
rial meningitis was made, and empiric treatment with
ceftriaxone sodium hydrate (CTRX) (120 mg/kg/day,
12-hourly) and meropenem hydrate (MEPM) (140 mg/kg/
day, 8-hourly) was started. To avoid neurological sequelae,
dexamethasone (0.60 mg/kg/day, 6-hourly) was also
administered for 2 days. The CSF culture was positive after
incubation at 37C for 2 days. Blood culture was positive
after incubation at 35C for 3 days. The isolates were
subsequently identiﬁed as H. inﬂuenzae by 16S rRNA gene
sequencing, followed by a basic local alignment search tool
(BLAST) search in the laboratory of Ubukata Kimiko at
the Kitasato Institute for Life Sciences Kitasato University.
On serotyping [15], no agglutination was observed with
antisera against the capsular serotypes a through f, leading
to categorization of the strain as nontypeable. On biotyping
[16], the organism failed to produce indole and to decar-
boxylate ornithine, but was able to hydrolyze urea, leading
to its categorization as biotype III. H. inﬂuenzae biotype
III could be distinguished from H. aegyptius by its fer-
mentation of xylose or by its growth on tryptic soy agar
containing X and V factors [17]. All of the CSF, blood, and
throat swab cultures yielded beta-lactamase-negative NTHi
biotype III. The minimum inhibitory concentrations (MIC)
of several antibiotics for the organism are listed in Table 1.
A repeat CSF culture on September 9 was also positive.
Blood culture was not repeated. On September 12, the
fever resolved and the signs of meningeal irritation were no
longer positive. We discontinued MEPM on the basis of the
result from antibiotic susceptibility testing. Repeat CSF
cultures on September 12 and 18 were both negative. On
September 24, CTRX was stopped when the serum CRP
had remained within the normal range for 7 days. On
September 28, she was discharged without any apparent
neurological sequelae (Fig. 1). Because of the unusual
ﬁnding of NTHi meningitis, further investigations were
performed on the child. The results revealed normal levels
of immunoglobulin G (IgG), IgG subtypes, IgA, IgM, CD4,
CD8, and of the blood complement components. Cranial
and paranasal sinus computed tomography and magnetic
resonance imaging of the head were normal. HIV testing
was not performed.
Table 1 Minimum inhibitory concentration of several antibiotics for
nontypeable Haemophilus inﬂuenzae biotype III isolated from the
cerebrospinal ﬂuid
Antibiotic MIC (lg/ml)
Ampicillin 0.25
Cefditoren \0.03
Cefcapene \0.03
Cefotaxime \0.03
Panipenem 1
Telithromycin 8
Clarithromycin \0.03
Meropenem \0.03
Ceftriaxone \0.03
Chloramphenicol 1
Levoﬂoxacin \0.5
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We report a rare case of meningitis and septicemia caused
by NTHi biotype III. This case demonstrates that NTHi
should be borne in mind as a potential pathogen that can
cause meningitis and septicemia, even in previously
healthy children. Almost all cases of H. inﬂuenzae men-
ingitis in unvaccinated children are caused by Hib or
biotype I strains [16]. In contrast with Hib, NTHi is pri-
marily recognized as a commensal organism in the upper
respiratory tract [3]. However, NTHi biotype III seems to
have the potential to cause invasive disease such as
meningitis [4, 9, 10] and septicemia [7, 9]. Therefore,
children presenting with invasive NTHi disease should be
promptly subjected to further evaluation and diagnostic
imaging for identifying predisposing factors such as head
trauma [4], CSF leakage [5], and immune compromise
[6].
Concerning the possible route of transmission of NTHi
biotype III, it seems likely that the meningitis and septi-
cemia in our patient were caused by the strain isolated from
her throat culture, because all strains isolated from the
CSF, blood, and throat belonged to identical biotypes and
the MIC distributions were almost identical.
A subgroup of NTHi strains is spontaneous capsule-
deﬁcient progeny of Hib strains called b
- strains. The b
-
strains might be generated by loss of their capsulation
ability through homologous recombination. The frequency
of b
- strains in Hib is 0.1–0.3% [14, 18, 19]. The b
- strains
cannot be ruled out for our patient’s strain, because the
slide agglutination test against the capsular serotypes are
not able to differentiate between NTHi and b
- strains.
Since the 1980s, when Hib conjugate vaccines were
introduced in many foreign countries, the incidence of Hib
meningitis has decreased dramatically. As a consequence,
NTHi has become relatively more important as a pathogen
for meningitis. In December 2008, Hib conjugate vaccine
was introduced in Japan. Since the introduction of Hib
conjugate vaccine, investigation of capsular serotypes is
necessary in all cases of H. inﬂuenzae meningitis, because
Hib vaccine does not protect against meningitis due to
nontypeable strains. We conclude that NTHi biotype III
must be borne in mind as a potential pathogen that can
cause meningitis and septicemia, even in previously heal-
thy children.
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Fig. 1 Clinical course of a 2-year-old girl with nontypeable Haemophilus inﬂuenzae meningitis. DEXA dexamethasone, CTRX ceftriaxone,
MEPM meropenem, WBC white blood cell, CRP C-reactive protein
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